Rhenman & Partners Asset Management’s Rapid Micro Biosystems RPID Stock Holding History

Rhenman & Partners Asset Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-127,152	Closed	-$165K	–	91
2023 Q1	$165K	Sell	127,152 -172,848	-58%	-$225K	0.02%	88
2022 Q4	$339K	Hold	300,000	–	–	0.04%	93
2022 Q3	$876K	Hold	300,000	–	–	0.09%	90
2022 Q2	$1.29M	Hold	300,000	–	–	0.15%	85
2022 Q1	$2.04M	Buy	300,000 +103,913	+53%	+$765K	0.2%	87
2021 Q4	$2.09M	Buy	+196,087	New	+$3.06M	0.14%	88

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Rhenman & Partners Asset Management's RPID Position: Q2 2023 in Review

Rhenman & Partners Asset Management sold out of Rapid Micro Biosystems (RPID) in Q2 2023, closing a stake of 127,152 shares — an estimated $165K sold.

Rhenman & Partners Asset Management first reported a position in RPID in Q4 2021 and held it in 6 quarters. The position peaked at $2.09M in Q4 2021. 24 funds tracked by Wall St. Rank hold RPID as of Q2 2023.

Rhenman & Partners Asset Management reported no remaining Rapid Micro Biosystems position as of Q2 2023 after selling out during the quarter.
Rhenman & Partners Asset Management sold 127,152 Rapid Micro Biosystems shares in Q2 2023, an estimated $165K.
Rhenman & Partners Asset Management first reported a position in Rapid Micro Biosystems in Q4 2021 and held it in 6 quarters.
Rhenman & Partners Asset Management's Rapid Micro Biosystems position peaked at $2.09M in Q4 2021.
24 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.